Clinical AI Infrastructure Platform
Enterprise AI infrastructure for health systems to deploy and manage clinical AI applications
Company profile
Company profile
Deepc is a healthcare technology company that develops clinical AI infrastructure specifically designed for health systems. The company's platform enables healthcare organizations to deploy, manage, and scale artificial intelligence solutions across their clinical operations and workflows. By providing foundational AI infrastructure, Deepc helps health systems overcome the technical and operational challenges associated with implementing AI in clinical settings. The company's approach focuses on creating a robust, scalable foundation that allows healthcare providers to leverage AI technologies effectively while maintaining compliance with healthcare regulations and standards. Deepc's solutions are designed to integrate with existing healthcare IT systems, enabling health systems to modernize their clinical operations and improve care delivery through AI-powered tools and capabilities.
Company description Deepc official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
No clinical focus areas are currently listed.
Hybrid deployment with recorded integration context.
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Enterprise AI infrastructure for health systems to deploy and manage clinical AI applications
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Journal of medical imaging (Bellingham, Wash.) · Mar 1, 2024
Longitudinal Assessment of Multiple Sclerosis Lesion Load With Synthetic Magnetic Resonance Imaging-A Multicenter Validation Study.Investigative radiology · May 1, 2023
Automated Detection of Ischemic Stroke and Subsequent Patient Triage in Routinely Acquired Head CT.Clinical neuroradiology · Jun 1, 2022
Faster and Better: How Anomaly Detection Can Accelerate and Improve Reporting of Head Computed Tomography.Diagnostics (Basel, Switzerland) · Feb 10, 2022
Automated Pathology Detection and Patient Triage in Routinely Acquired Head Computed Tomography Scans.Investigative radiology · Sep 1, 2021
Rates of testing for HIV in the presence of serodiscordant UAI among HIV-negative gay men in committed relationships.AIDS and behavior · Oct 1, 2012
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Deepc's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.